Evidence map›Paper›PMID 27127234›Full record

ArticleScience (New York, N.Y.)2016

Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation.

Alex Rialdi, Laura Campisi, Nan Zhao, Arvin Cesar Lagda, Colette Pietzsch, Jessica Sook Yuin Ho, Luis Martinez-Gil, Romain Fenouil, Xiaoting Chen, Megan Edwards and 15 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. DNA topological regulation in RNA polymerase II transcription.Cellular & molecular biology letters · 2026
    Review
  10. The Roles of Topoisomerases in Transcriptional Regulation.International journal of molecular sciences · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Control of Inflammatory Response by Tissue Microenvironment.bioRxiv : the preprint server for biology · 2025
    Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Alex Rialdi *Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Laura Campisi *Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Nan ZhaoDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Arvin Cesar LagdaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Colette PietzschDepartment of Pathology, Microbiology, and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Jessica Sook Yuin HoLaboratory of Methyltransferases in Development and Disease, Institute of Molecular and Cell Biology, Singapore.
Luis Martinez-GilDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Romain FenouilIcahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Xiaoting ChenCenter for Autoimmune Genomics and Etiology (CAGE) and Divisions of Biomedical Informatics and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Megan EdwardsDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Giorgi MetreveliDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Stefan JordanDepartment of Oncological Sciences, Tisch Cancer Institute and Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Zuleyma PeraltaIcahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Cesar Munoz-FontelaHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Nicole BouvierDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Miriam MeradDepartment of Oncological Sciences, Tisch Cancer Institute and Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Jian JinDepartment of Structural and Chemical Biology, Department of Oncological Sciences, and Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Matthew WeirauchCenter for Autoimmune Genomics and Etiology (CAGE) and Divisions of Biomedical Informatics and Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Sven HeinzDepartment of Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Chris BennerSalk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Harm van BakelIcahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Christopher BaslerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Alexander BukreyevDepartment of Pathology, Microbiology, and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Ivan MarazziDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Funding

Virus CoreU19AI106754 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ALBRECHT, RANDY A. · 2013 to 2017
$26.0M
Therapeutics Targeting Filoviral interferon-antagonist and replication functionsU19AI109664 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BASLER, CHRISTOPHER F · 2014 to 2018
$15.8M
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
Molecular mechanisms of immune dysregulation by filoviral interferon U19AI109945 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BASLER, CHRISTOPHER F · 2014 to 2018
$9.5M
ERK control of Dendritic Cell Differentiation, Homeostasis and DiseaseR01CA154947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CARL E ALLEN, MIRIAM MERAD · 2011 to 2026
$7.0M
Multi-level analysis of influenza virus polymerase and its role in pathogenesisR01AI113186 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARAZZI, IVAN, VAN BAKEL, HARM · 2015 to 2019
$3.0M
Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
SETX, antiviral response and genetic diseasesR56AI114770 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARAZZI, IVAN · 2015 to 2015
$421k
NCI NIH HHS R01 CA154947NIAID NIH HHS 1R56AI114770-01A1NIAID NIH HHS AI07647NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI113186NIAID NIH HHS R56 AI114770NIAID NIH HHS T32 AI007647NIAID NIH HHS U19 AI106754NIAID NIH HHS U19AI106754NIAID NIH HHS U19 AI109664NIAID NIH HHS U19AI109664NIAID NIH HHS U19 AI109945NIAID NIH HHS U19AI109945NIH HHS S10 OD018522PHS HHS 1R01AN3663134PHS HHS HHSN272201400008C
6 · The paper itself

Abstract

The host innate immune response is the first line of defense against pathogens and is orchestrated by the concerted expression of genes induced by microbial stimuli. Deregulated expression of these genes is linked to the initiation and progression of diseases associated with exacerbated inflammation. We identified topoisomerase 1 (Top1) as a positive regulator of RNA polymerase II transcriptional activity at pathogen-induced genes. Depletion or chemical inhibition of Top1 suppresses the host response against influenza and Ebola viruses as well as bacterial products. Therapeutic pharmacological inhibition of Top1 protected mice from death in experimental models of lethal inflammation. Our results indicate that Top1 inhibition could be used as therapy against life-threatening infections characterized by an acutely exacerbated immune response.

Indexed as

AnimalsAzepinesCamptothecinDNA Topoisomerases, Type IEbolavirusFlavonoidsGene Expression RegulationHEK293 CellsHemorrhagic Fever, EbolaHost-Pathogen InteractionsHumansImmunity, InnateInflammationInfluenza A virusInterferon-betaMicealvocidibAzepinesCamptothecinDNA Topoisomerases, Type IFlavonoidsInterferon-beta(+)-JQ1 compoundPiperidinesPositive Transcriptional Elongation Factor BRNA Polymerase IITopoisomerase I InhibitorsTopotecanTriazoles

Identifiers

PMID27127234
PMCPMC5193222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.